MARKET

ASBP

ASBP

Aspire Biopharma Holdings Inc
NASDAQ
6.00
-0.46
-7.05%
Pre Market: 6.07 +0.07 +1.17% 07:07 06/29 EDT
OPEN
6.30
PREV CLOSE
6.46
HIGH
6.54
LOW
5.99
VOLUME
793
TURNOVER
0
52 WEEK HIGH
1,050.36
52 WEEK LOW
3.309
MARKET CAP
7.77M
P/E (TTM)
-0.0355
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ASBP last week (0622-0626)?
Weekly Report · 1h ago
Aspire Biopharma posts June 2026 investor presentation for on-demand viewing
PUBT · 2d ago
Aspire unit Buzz Bomb Caffeine launches BUZZ BOMB 50 mg caffeine stick packs on Amazon
PUBT · 4d ago
Aspire Biopharma posts investor deck on sublingual drug-delivery platform, lead sublingual aspirin program
PUBT · 5d ago
Aspire Biopharma to present at Life Sciences Virtual Investor Forum
PUBT · 5d ago
Aspire Biopharma Holders Approve Warrant and Share Issuance
TipRanks · 6d ago
Aspire Biopharma stockholders approve warrant share issuance proposal at special meeting
PUBT · 6d ago
Weekly Report: what happened at ASBP last week (0615-0619)?
Weekly Report · 06/22 10:17
More
About ASBP
Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company. The Company is a developer of multi-faceted patent-pending drug delivery technology. It is engaged in developing and marketing the disruptive technology for novel sublingual delivery mechanisms for known drugs. Its patent pending delivery system includes components formulated to allow sublingual absorption of drugs into the blood stream, thus by-passing the gastrointestinal tract. Its delivery technology is focused on different active pharmaceutical ingredients (APIs) and other bioactive substances, spanning both small and large molecule therapeutics, nutraceuticals and supplements. Its Sublingual Aspirin Product addresses cardiology emergencies and pain management. Its other products include Melatonin, Vitamins, Erectile Dysfunction Medication, Caffeine Products, and Other Products, which includes anti-nausea products (meclizine and ondansetron), alprazolam, clopidogrel, microdose nicotine, and semaglutide.

Webull offers Aspire Biopharma Holdings Inc stock information, including NASDAQ: ASBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASBP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASBP stock methods without spending real money on the virtual paper trading platform.